This project will investigate mammalian DNA polymerase ? (Pol ?), the defining enzyme for repair of DNA double-strand breaks by polymerase theta-mediated end joining (TMEJ). This is Project 1 (?Cellular requirements for Pol ??) which is part of a Program Project titled, ?Polymerase theta, genome instability, and cancer?. TMEJ mechanism and biological role is not well understood. Importantly, loss of Pol ? is tolerated in normal cells but is lethal in many cancers, making it an attractive target for cancer therapy. Unfortunately, the major knowledge gaps in both the mechanism of action and biological role for Pol ? have undercut the development of safe, effective targeting strategies. Project 1 will identify requirements for Pol ? function by leveraging existing specialized cellular assays and a robust platform for identifying genetic interactions. We will additionally develop new methods to probe the different roles of Pol ? in cellular repair. This project aims to fill several major gaps in knowledge:
In Aim 1 ?We will identify requirements for cellular TMEJ?. We will use cell lines defective in specific Pol q activities and other factors linked to TMEJ, and assess the impact of these defects on cellular TMEJ.
In Aim 2 ?We will determine cellular contexts that engage TMEJ?. We will assess the extent to which blocks to late steps in another repair pathway engage TMEJ (2A). We will also employ high throughput sequencing to investigate the impact of Pol ? loss on genomic scars caused by a chemotherapeutic agent (2B).
In Aim 3 ?We will employ a genetic screen to identify new mediators of TMEJ?. We will identify a set of genes in the same pathway as Pol ?, by finding those genes that when mutated are lethal in a panel of cells defective in other repair pathways that renders them acutely dependent on TMEJ for survival. The research work will be highly coordinated within the Program Project with the other three Projects and the three Cores. Our combined diverse approaches include molecular biology, biochemistry, structural biology, and biophysics. We will employ mutants and initiate experiments based on results shared with projects 2, 3, and 4, which will be constantly monitored with feedback via Core A. Protein purification will be supported by Core B, and cell line construction by Core C.
This project will investigate mammalian DNA polymerase theta, the defining enzyme for an important pathway that repairs genomic damage. Project 1 (this project) will help clarify mechanism and biological role of this pathway as part of a multidisciplinary program project; our work together will allow us to exploit the vulnerabilities that arise when this repair pathway is targeted as a cancer therapy.
